Skip to main content
. Author manuscript; available in PMC: 2019 Nov 27.
Published in final edited form as: Chembiochem. 2018 May 27:10.1002/cbic.201800285. doi: 10.1002/cbic.201800285

Scheme 3.

Scheme 3.

Proposed biosynthetic pathway for TNL A (1) supported by the isolation of congeners or shunt metabolites 411, as indicated by the dashed arrows. A) The four core proteins, TnlT1–T4, construct the diterpenoid scaffold and elongate the side chain. Then, a series of oxidative reactions form the γ-butyrolactone moiety and hydroxylate the C-18 and C-12 positions before acylation of the chloroanthranilate moiety. Finally, the N- and O-methylations, catalyzed by TnlP5 and TnlM1, respectively, complete the biosynthesis, although their timing is still unknown. IPP: isopentenyl diphosphate, DMAPP: dimethylallyl diphosphate, GGPP: geranylgeranyl diphosphate. B) Biosynthesis of the chloroanthranilate moiety from l-tryptophan follows that of tryptophan degradation through the kynurenine pathway. Chemical transformations are colored red; for multiple transformations in one step, red and blue are used.